Suppr超能文献

四种体外检测方法用于预测化学品皮肤致敏性的实验室内部验证。

Intralaboratory validation of four in vitro assays for the prediction of the skin sensitizing potential of chemicals.

机构信息

BASF SE, Experimental Toxicology and Ecology, Germany.

出版信息

Toxicol In Vitro. 2011 Sep;25(6):1162-8. doi: 10.1016/j.tiv.2011.05.030. Epub 2011 Jun 7.

Abstract

Allergic contact dermatitis is induced by repeated skin contact with an allergen. Assessment of the skin sensitizing potential of chemicals, agrochemicals, and especially cosmetic ingredients is currently performed with the use of animals. Animal welfare and EU legislation demand animal-free alternatives reflected in a testing and marketing ban for cosmetic ingredients beginning in 2013. The underlying mechanisms of induction and elicitation of skin sensitization are complex and a chemical needs to comply several properties being skin sensitizing. To account for the multitude of events in the induction of skin sensitization an in vitro test system will consist of a battery of various tests. Currently, we performed intralaboratory validations of four assays addressing three different events during induction of skin sensitization. (1) The Direct Peptide Reactivity Assay (DPRA) according to Gerberick and co-workers (Gerberick et al., 2004) using synthetic peptides and HPLC analysis. (2) Two dendritic cell activation assays based on the dendritic cell like cell lines U-937 and THP-1 and flow cytometric detection of the maturation markers CD54 and/or CD86 (Ashikaga et al., 2006; Python et al., 2007; Sakaguchi et al., 2006). (3) Antioxidant response element (ARE)-dependent gene activity in a HaCaT reporter gene cell line (Emter et al., 2010). We present the results of our intralaboratory validation of these assays with 23 substances of known sensitizing potential. The sensitivity, specificity, and accuracy of the individual tests were obtained by comparison to human epidemiological data as well as to data from animal tests such as the local lymph node assay.

摘要

变应性接触性皮炎是由过敏原反复接触皮肤引起的。目前,化学物质、农药和特别是化妆品成分的皮肤致敏潜力评估是使用动物进行的。动物福利和欧盟立法要求使用无动物替代方法,这反映在 2013 年开始对化妆品成分进行测试和销售禁令。皮肤致敏的诱导和激发的潜在机制很复杂,一种化学物质需要符合多种皮肤致敏的特性。为了考虑到皮肤致敏诱导中的多种事件,体外测试系统将由各种测试组成。目前,我们对四个检测方法进行了实验室内部验证,这些方法涉及皮肤致敏诱导过程中的三个不同事件。(1)根据 Gerberick 等人的直接肽反应测定法(DPRA)(Gerberick 等人,2004),使用合成肽和 HPLC 分析。(2)两种基于树突状细胞样细胞系 U-937 和 THP-1 的树突状细胞激活测定法,以及成熟标志物 CD54 和/或 CD86 的流式细胞术检测(Ashikaga 等人,2006;Python 等人,2007;Sakaguchi 等人,2006)。(3)在 HaCaT 报告基因细胞系中抗氧化反应元件(ARE)依赖性基因活性(Emter 等人,2010)。我们介绍了这些方法的实验室内部验证结果,涉及 23 种已知致敏潜力的物质。通过与人类流行病学数据以及动物测试(如局部淋巴结测定)的数据进行比较,获得了各个测试的灵敏度、特异性和准确性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验